Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

This study found that while female pattern hair loss in young to middle-aged women was commonly associated with markers of hyperandrogenism and specific histopathological features, its exact causes and treatment remain unclear.

This discussion highlights that alopecia areata incognita is challenging to diagnose and treat, with systemic corticosteroids potentially leading to remission when local treatments fail.

This review discusses various causes of hair loss, emphasizing the importance of a structured diagnostic approach, and reports no new clinical findings.

Hair loss can be caused by hormones, illness, autoimmune disorders, or vitamin deficiencies, and treatments vary depending on the type.

This review outlines various causes and manifestations of hair loss, highlighting that each type has distinct underlying mechanisms and requires specific treatment approaches, without reporting new clinical results.

This review discusses treatment approaches for androgenetic alopecia, highlighting that drug therapies like minoxidil and finasteride are promising for men, while antiandrogens and topical minoxidil show good results in women; it reports no new results.

This study found that adolescents with androgenetic alopecia showed distinct hormonal profiles between boys and girls, with concurrent metabolic dysfunction present in both sexes, highlighting the need for sex-specific diagnosis and management approaches.

This review discusses loose anagen hair syndrome in children, characterized by non-scarring alopecia and increased hair shedding, and reports no new results; topical minoxidil may be used as a treatment.

This review discusses the genetic factors and single nucleotide polymorphisms related to androgenic alopecia, emphasizing androgen receptors, but reports no new clinical results.

This report describes two cases of monilethrix in Afghan siblings, detailing the hair disorder's clinical presentation and potential influences on hair growth, such as hormonal changes and iron supplementation.

This review discusses female androgenic alopecia, highlighting its potential difference from male androgenic alopecia and notes increased incidence, but reports no new clinical findings.

This review discusses recent advances in hair follicle research, highlighting therapeutic and cosmetic applications, but reports no new study results.

This study reports that trichoscopy and histopathology can effectively diagnose alopecia areata incognito and differentiate it from telogen effluvium or androgenetic alopecia, aiding clinicians in better hair regrowth management.

This review explores the causes and diagnostic methods for androgenetic alopecia but reports no new clinical results, underlining the importance of developing new treatments.

This article reviews the differences between scarring and non-scarring alopecias and describes diagnostic methods but reports no new clinical findings.

This review discusses common skin appendage diseases, including their pathophysiology and treatments, but does not report new results.

This letter reports three cases of diffuse hair loss linked to hyperprolactinaemia but does not present new research findings.

This study found that the TrichoScan software effectively differentiated between androgenetic alopecia and telogen effluvium in women with diffuse hair loss, aligning with clinical diagnoses.

This article presents a case of syphilitic alopecia in a man, where treatment with benzathine penicillin G led to dramatic hair regrowth and resolution of syphilitic lesions within three months.

This article reviews the potential impact of melatonin on hair growth, noting its benefits observed in animals, but reports no clinical results in humans to date.

This study found that among Japanese women with diffuse hair loss, decreased hair density without changes in vellus hair was the most common and distinct pattern observed, highlighting differences from previous observations in other populations.

This review discusses the evaluation and management of male baldness and related conditions, but reports no new clinical results.

In this case report, estrogen substitution therapy slightly increased hair volume in a 22-year-old patient with genetic predisposition to hair loss and alopecia caused by past treatment for leukemia, but hair loss returned after stopping the therapy.

This study suggests that hypersensitivity and increased serum IgE levels might contribute to the pathogenesis of diffuse alopecia areata through intense local inflammatory infiltration.

Diffuse alopecia in women may be related to androgens and iron deficiency, and basic hormone and nutrient screening is useful.

Syphilis can cause hair loss without other symptoms and should be considered when diagnosing unexplained hair loss.

This article discusses the extent of investigation needed for diffuse alopecia in women but reports no new findings.

In this study, researchers explored the causes and treatment strategies for diffuse telogen effluvium, focusing on 60 patients with the condition linked to iron deficiency anemia, comparing the effectiveness of ferrous salts alone versus combined with Quilib lotion.

In this observational study, most patients with multiple sclerosis on teriflunomide who experienced hair thinning reported it as mild or moderate and largely recovered while continuing treatment.

This study found that the presence of CD3(+) T-cells within empty follicular fibrous tracts is a reliable indicator for diagnosing diffuse alopecia areata instead of pattern hair loss.